Women’s Hormones & the Future of Longevity Medicine | Dr. Amy Killen

This episode explores how women’s hormones, aging, regenerative therapies, and technology are shaping the next era of longevity medicine. Dr. Amy Killen shares her evolution from ER doctor to multi-company entrepreneur, her work in stem cells and full-body regenerative procedures, and the role of diagnostics, AI, and hormone optimization in midlife women’s health. You’ll get an inside look at the queen phase of perimenopause, the future of longevity clinics, and how women can stay proactive as they age.

KEY TOPICS

Estrogen, perimenopause and the queen phase of women’s midlifeDr. Killen’s shift from ER medicine to entrepreneurship in longevityStem cells, exosomes and whole-body regenerative therapiesReputable Health, Hop Box and Humanát Health’s tech-enabled clinical modelAI-driven care plans, advanced diagnostics and the future of preventive longevity careTIMESTAMPS

[00:00] Estrogen as a forgotten longevity drug and the mental health impact of perimenopause

[00:56] Show intro and framing women’s health, resilience and personal transformation

[01:27] ER burnout, single motherhood and the moment everything shifted

[03:23] Leaving the ER and confronting criticism around hormones and regenerative medicine

[04:08] Partnering with Docere Clinics and developing the Full Body Stem Cell Makeover

[06:33] Stacking stem cells, exosomes, peptides, light therapy and sound therapy

[08:10] Transformations in pain, sexual health and functional recovery using stem cells

[10:09] Musculoskeletal outcomes and delaying joint replacement surgeries

[10:57] Skin quality improvements, subtle rejuvenation and hair restoration in women